Literature DB >> 24075693

Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.

Hui Ye1, Xueli Bai1, Hua Gao1, Li Li1, Chunxiao Wu1, Xinping Sun1, Chunzhi Zhang1, Yajuan Shen1, Jian Zhang2, Zhiming Lu3.   

Abstract

AIMS: We tested whether urinary podocalyxin-positive element (PCX+EL) can be a marker of early stage of diabetic nephropathy (DN).
METHODS: DN patients (n=68) and health controls (n=28) were enrolled in this study. Patients were classified into three groups: normoalbuminuria, microalbuminuria and macroalbuminuria. Urinary PCX+EL, serum cystatin C (Scys C) and serum creatinine (SCr) were quantified, and correlations between urinary PCX+EL and urinary albumin, Scys C and SCr were examined. The comparison of diagnosis efficiency among urinary PCX+EL, Scys C and SCr was made by receiver operating characteristic (ROC) analysis.
RESULTS: Urinary PCX+EL, Scys C and SCr significantly increased in DN patients compared with controls. Urinary PCX+EL increased significantly in all three patients groups compared with controls. However, the concentration of Scys C and SCr did not increase in normoalbuminuria group. Urinary albumin, Scys C and SCr correlated with urinary PCX+EL. ROC curve analysis indicated that area under the curve (AUC) of urinary PCX+EL (0.966) is higher than that of Scys C (0.857) and SCr (0.726) for discriminating nephropathy between DN patients and controls.
CONCLUSION: Urinary PCX+EL may be a noninvasive marker for the early stage of DN.
© 2014.

Entities:  

Keywords:  Diabetic nephropathy; Flow cytometry; Podocalyxin; Podocyte

Mesh:

Substances:

Year:  2013        PMID: 24075693     DOI: 10.1016/j.jdiacomp.2013.08.006

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  10 in total

1.  The Podocyte Count Detected by an Improved Immunocytochemical Method has Higher Diagnostic Efficiency than Enzyme-Linked Immunosorbent Assay and Serum Cystatin C to Evaluate the Early Stage Damage of Glomerular.

Authors:  Li Li; Jing Wang; Yi Li; Chao Lu; Yiqing Liu; Zhifen Zhang; Zi-E Wang; Jian Zhang; Zhiming Lu
Journal:  J Clin Lab Anal       Date:  2016-07-20       Impact factor: 2.352

2.  Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.

Authors:  Chayanut Suwanpen; Phonethipsavanh Nouanthong; Veeravich Jaruvongvanich; Krit Pongpirul; Wannarat Amornnimit Pongpirul; Asada Leelahavanichkul; Talerngsak Kanjanabuch
Journal:  J Nephrol       Date:  2015-04-24       Impact factor: 3.902

Review 3.  Novel urinary biomarkers in early diabetic kidney disease.

Authors:  Atsuko Kamijo-Ikemori; Takeshi Sugaya; Kenjiro Kimura
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

4.  Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model.

Authors:  Abdallah Mahmoud El-Ebidi; Tahia H Saleem; Mohamed Gamal El-Din Saadi; Hala Abdallah Mahmoud; Zeinab Mohamed; Hoda S Sherkawy
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-20       Impact factor: 3.168

5.  A comprehensive analysis and annotation of human normal urinary proteome.

Authors:  Mindi Zhao; Menglin Li; Yehong Yang; Zhengguang Guo; Ying Sun; Chen Shao; Mingxi Li; Wei Sun; Youhe Gao
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

6.  Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus.

Authors:  Ligia Petrica; Sorin Ursoniu; Florica Gadalean; Adrian Vlad; Gheorghe Gluhovschi; Victor Dumitrascu; Daliborca Vlad; Cristina Gluhovschi; Silvia Velciov; Flaviu Bob; Petru Matusz; Oana Milas; Alina Secara; Anca Simulescu; Roxana Popescu
Journal:  Diabetol Metab Syndr       Date:  2017-05-06       Impact factor: 3.320

7.  Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study.

Authors:  Adrian Vlad; Mihaela Vlad; Ligia Petrica; Sorin Ursoniu; Florica Gadalean; Roxana Popescu; Daliborca Vlad; Victor Dumitrascu; Gheorghe Gluhovschi; Cristina Gluhovschi; Silvia Velciov; Flaviu Bob; Petru Matusz; Alina Secara; Anca Simulescu; Dragos Catalin Jianu
Journal:  Ren Fail       Date:  2016-11-13       Impact factor: 2.606

8.  Transplantation of adipose-derived mesenchymal stem cell sheets directly into the kidney suppresses the progression of renal injury in a diabetic nephropathy rat model.

Authors:  Shunsuke Takemura; Tatsuya Shimizu; Masatoshi Oka; Sachiko Sekiya; Tetsuya Babazono
Journal:  J Diabetes Investig       Date:  2019-11-06       Impact factor: 4.232

9.  Association between Renal Podocalyxin Expression and Renal Dysfunction in Patients with Diabetic Nephropathy: A Single-Center, Retrospective Case-Control Study.

Authors:  Rongzhen Wang; Can Yao; Feng Liu
Journal:  Biomed Res Int       Date:  2020-04-03       Impact factor: 3.411

10.  Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus.

Authors:  Shang-Feng Tsai; Chien-Wei Su; Ming-Ju Wu; Cheng-Hsu Chen; Chia-Po Fu; Chin-San Liu; Mingli Hsieh
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.